Skip to main content

ARS Pharmaceuticals, Inc.

SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671858

No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in ARS Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
208
+7 vs. Q1 2026
Shares held
90.6M
−3.48M (−3.7%) vs. Q1 2026
Total value
$726.0M
−$31.4M (−4.1%) vs. Q1 2026
New holders
38
72 more added
Sold out
31
56 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SPRY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 208 institutions
Q1 2021: 68 institutionsQ2 2021: 76 institutionsQ3 2021: 74 institutionsQ4 2021: 72 institutionsQ1 2022: 70 institutionsQ2 2022: 64 institutionsQ3 2022: 61 institutionsQ4 2022: 73 institutionsQ1 2023: 90 institutionsQ2 2023: 92 institutionsQ3 2023: 97 institutionsQ4 2023: 100 institutionsQ1 2024: 113 institutionsQ2 2024: 115 institutionsQ3 2024: 151 institutionsQ4 2024: 166 institutionsQ1 2025: 184 institutionsQ2 2025: 188 institutionsQ3 2025: 188 institutionsQ4 2025: 191 institutionsQ1 2026: 203 institutionsQ2 2026: 208 institutions
Value heldQ2 2026: $726.0M
Q1 2021: $1.21BQ2 2021: $864.6MQ3 2021: $288.4MQ4 2021: $200.5MQ1 2022: $94.7MQ2 2022: $110.5MQ3 2022: $160.4MQ4 2022: $427.9MQ1 2023: $347.7MQ2 2023: $369.0MQ3 2023: $251.6MQ4 2023: $358.5MQ1 2024: $612.1MQ2 2024: $533.0MQ3 2024: $928.4MQ4 2024: $752.3MQ1 2025: $958.9MQ2 2025: $1.48BQ3 2025: $840.4MQ4 2025: $1.05BQ1 2026: $757.5MQ2 2026: $726.0M
Institutions holding SPRY and their total value by quarter
QuarterHoldersValue
Q2 2026208$726.0M
Q1 2026203$757.5M
Q4 2025191$1.05B
Q3 2025188$840.4M
Q2 2025188$1.48B
Q1 2025184$958.9M
Q4 2024166$752.3M
Q3 2024151$928.4M
Q2 2024115$533.0M
Q1 2024113$612.1M
Q4 2023100$358.5M
Q3 202397$251.6M
Q2 202392$369.0M
Q1 202390$347.7M
Q4 202273$427.9M
Q3 202261$160.4M
Q2 202264$110.5M
Q1 202270$94.7M
Q4 202172$200.5M
Q3 202174$288.4M
Q2 202176$864.6M
Q1 202168$1.21B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding ARS Pharmaceuticals, Inc.; share changes are against Q1 2026.

Institutions holding SPRY in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Sr One Capital Management, LP4,012,903$32.1M3.09%00.0%Unchanged
Standard Life Aberdeen plc4,170,629$33.4M0.05%+57,012+1.4%Added
Tyro Capital Management LLC4,459,337$35.7M8.01%+1,490,738+50.2%Added
BlackRock, Inc.5,311,319$42.5M0.00%+299,065+6.0%Added
Deerfield Management Company, L.P. (Series C)7,503,812$60.1M0.63%00.0%Unchanged
OrbiMed Advisors LLC8,288,510$66.4M1.26%00.0%Unchanged
Rubric Capital Management LP8,540,861$68.4M0.63%+540,861+6.8%Added
Ra Capital Management, L.P.10,860,977$87.0M0.76%00.0%Unchanged
Franklin Resources Inc0$00.00%−3,278,549−100.0%Sold out
Bamco Inc0$00.00%−1,273,341−100.0%Sold out
Nextech Invest, Ltd.0$00.00%−610,703−100.0%Sold out
First Trust Advisors LP0$00.00%−422,038−100.0%Sold out
Landscape Capital Management, L.L.C.0$00.00%−168,789−100.0%Sold out
Wexford Capital LP0$00.00%−130,313−100.0%Sold out
Knights of Columbus Asset Advisors LLC0$00.00%−130,032−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−96,093−100.0%Sold out
Alps Advisors Inc0$00.00%−80,830−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−46,558−100.0%Sold out
DRW Securities, LLC0$00.00%−43,665−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−40,920−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−15,924−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−14,787−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−13,855−100.0%Sold out
Bridgefront Capital, LLC0$00.00%−12,926−100.0%Sold out
Oppenheimer & Co Inc0$00.00%−12,439−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−11,873−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−11,811−100.0%Sold out
Blair William & Co0$00.00%−10,825−100.0%Sold out
Alpine Woods Capital Investors, LLC0$00.00%−10,000−100.0%Sold out
Eastern Bank0$00.00%−750−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−349−100.0%Sold out
Golden State Wealth Management, LLC0$00.00%−484−100.0%Sold out
Spire Wealth Management0$00.00%−400−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−347−100.0%Sold out
Fifth Third Bancorp0$00.00%−225−100.0%Sold out
Root Financial Partners, LLC0$00.00%−58−100.0%Sold out
Pinnacle Wealth Planning Services, Inc.0$00.00%−17−100.0%Sold out
MAI Capital Management0$00.00%−5−100.0%Sold out
Freestone Grove Partners LP0$00.00%−2−100.0%Sold out
Janus Henderson Group PLC––––Not filed
CWM, LLC––––Not filed